Pharvaris N.V. Files 6-K for Q2 2025

Ticker: PHVS · Form: 6-K · Filed: 2025-08-12T00:00:00.000Z

Sentiment: neutral

Topics: financial-update, 6-K, quarterly-filing

TL;DR

Pharvaris 6-K shows Q2 2025 financials, including clinical and personnel costs.

AI Summary

Pharvaris N.V. filed a 6-K report on August 12, 2025, for the period ending June 30, 2025. The filing includes financial data such as gross carrying amounts and issued capital as of June 30, 2025. It also details clinical and personnel expenses for the first six months of 2025, alongside comparative data from 2024.

Why It Matters

This filing provides investors with an update on Pharvaris's financial position and operational expenses for the second quarter of 2025, crucial for assessing the company's ongoing development and resource allocation.

Risk Assessment

Risk Level: low — This is a routine financial filing (6-K) providing standard financial data and does not indicate any unusual events or significant changes.

Key Numbers

2025-06-30 — Period End Date (Financial reporting period)
2024-06-30 — Comparative Period End Date (Financial reporting period)
2025-01-01 to 2025-06-30 — Clinical Expenses Period (Operational costs)
2024-01-01 to 2024-06-30 — Comparative Clinical Expenses Period (Operational costs)

Key Players & Entities

Pharvaris N.V. (company) — Filer
0000950170-25-107316 (filing_id) — Accession Number
20250630 (date) — Period of Report
20250812 (date) — Filing Date

FAQ

What is the gross carrying amount reported by Pharvaris N.V. as of June 30, 2025?

The filing indicates a 'ifrs-full:GrossCarryingAmountMember' for 2025-06-30, but the specific dollar amount is not detailed in the provided text snippet.

What were the clinical expenses for Pharvaris N.V. in the first half of 2025?

The filing lists 'phvs:ClinicalExpensesMember' for the period 2025-01-01 to 2025-06-30, but the specific dollar amount is not detailed in the provided text snippet.

What is the issued capital of Pharvaris N.V. as of June 30, 2025?

The filing references 'ifrs-full:IssuedCapitalMember' for 2025-06-30, but the specific dollar amount is not provided in the text snippet.

What were the personnel expenses for Pharvaris N.V. in the first half of 2024?

The filing indicates 'phvs:PersonnelExpensesMember' for the period 2024-01-01 to 2024-06-30, but the specific dollar amount is not detailed in the provided text snippet.

What is the filing date for this 6-K report?

The filing date is August 12, 2025 (20250812).

From the Filing

0000950170-25-107316.txt : 20250812 0000950170-25-107316.hdr.sgml : 20250812 20250812161022 ACCESSION NUMBER: 0000950170-25-107316 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 89 CONFORMED PERIOD OF REPORT: 20250630 FILED AS OF DATE: 20250812 DATE AS OF CHANGE: 20250812 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pharvaris N.V. CENTRAL INDEX KEY: 0001830487 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40010 FILM NUMBER: 251206775 BUSINESS ADDRESS: STREET 1: J.H. OORTWEG 21 STREET 2: 2333 CH LEIDEN CITY: LEIDEN STATE: P7 ZIP: 00000 BUSINESS PHONE: 31 (0)71 203 6410 MAIL ADDRESS: STREET 1: J.H. OORTWEG 21 STREET 2: 2333 CH LEIDEN CITY: LEIDEN STATE: P7 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: Pharvaris, B.V. DATE OF NAME CHANGE: 20201029 6-K 1 phvs-20250630.htm 6-K 6-K 0001830487 Q2 2025 false --12-31 2025-06-30 0001830487 2023-12-31 0001830487 phvs:RestrictedStockUnitsMember 2024-12-31 0001830487 ifrs-full:GrossCarryingAmountMember 2025-06-30 0001830487 ifrs-full:IssuedCapitalMember 2025-06-30 0001830487 phvs:ClinicalExpensesMember 2025-01-01 2025-06-30 0001830487 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2024-01-01 2024-06-30 0001830487 country:US 2024-12-31 0001830487 phvs:PersonnelExpensesMember 2024-01-01 2024-06-30 0001830487 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember phvs:BlackScholesFormulaMember 2025-03-12 2025-03-12 0001830487 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2024-12-31 0001830487 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-12-31 0001830487 phvs:PersonnelRelatedAccrualsMember 2025-06-30 0001830487 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2025-01-01 2025-06-30 0001830487 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2025-01-01 2025-06-30 0001830487 2025-04-01 2025-04-01 0001830487 phvs:PharvarisIncMember 2024-01-01 2024-06-30 0001830487 phvs:StockOptionsMember 2024-12-31 0001830487 ifrs-full:GrossCarryingAmountMember 2023-12-31 0001830487 country:US 2025-06-30 0001830487 phvs:MoneyMarketFundMember ifrs-full:AtCostMember 2024-12-31 0001830487 phvs:ConsultingProfessionalAndAuditLiabilityMember 2024-12-31 0001830487 phvs:MorganStanleyCoLlcAndLeerinkPartnersLlcMember phvs:PreFundedWarrantsMember 2023-12-31 0001830487 phvs:PersonnelExpensesMember 2025-04-01 2025-06-30 0001830487 ifrs-full:SharePremiumMember 2025-06-30 0001830487 phvs:RestrictedStockUnitsMember ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2025-01-01 2025-06-30 0001830487 phvs:StockOptionsMember 2025-06-30 0001830487 phvs:OfficeLeaseMember 2024-12-31 0001830487 phvs:LicenseCostsMember 2025-01-01 2025-06-30 0001830487 ifrs-full:SharePremiumMember 2024-06-30 0001830487 phvs:LicenseCostsMember 2025-04-01 2025-06-30 0001830487 phvs:LicenseCostsMember 2024-01-01 2024-06-30 0001830487 2025-02-01 2025-02-01 0001830487 ifrs-full:IssuedCapitalMember 2023-12-31 0001830487 phvs:NonclinicalExpensesMember 2024-04-01 2024-06-30 0001830487 phvs:PharvarisHoldingsBvMember 2025-01-01 2025-06-30 0001830487 ifrs-full:SharePremiumMember 2024-12-31 0001830487 2025-03-01 2025-03-01 0001830487 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2023-12-31 0001830487 ifrs-full:OrdinarySharesMember 2025-06-30 0001830487 phvs:StockOptionsGrantedToBoardOfDirectorsMember phvs:BlackScholesFormulaMember 2025-03-12 0001830487 phvs:IntellectualPropertyCostsMember 2025-01-01 2025-06-30 0001830487 2025-01-01 2025-06-30 0001830487 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember phvs:BlackScholesFormulaMember 2025-03-12 0001830487 phvs:NonclinicalAccruedLiabilitiesMember 2024-12-31 0001830487 phvs:ClinicalExpensesMember 2025-04-01 2025-06-30 0001830487 phvs:PharvarisHoldingsBvMember 2024-01-01 2024-06-30 0001830487 ifrs-full:SharePremiumMember 2023-12-31 0001830487 2025-06-30